{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:51:50Z","timestamp":1759366310327,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.revmed.2005.03.002","type":"journal-article","created":{"date-parts":[[2005,4,9]],"date-time":"2005-04-09T07:57:04Z","timestamp":1113033424000},"page":"599-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Une cause \u00e0 conna\u00eetre d'\u00e9l\u00e9vation de chromogranine A\u00a0: les inhibiteurs de la pompe \u00e0 protons"],"prefix":"10.1016","volume":"26","author":[{"given":"M.","family":"Lopez-Sublet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Attignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.-M.","family":"Nazal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Krivitzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-J.","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2005.03.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/erc.0.0110001","article-title":"Neuroendocrine tumours","volume":"11","author":"Barakat","year":"2004","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.revmed.2005.03.002_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1530\/eje.0.1500299","article-title":"Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man","volume":"150","author":"Giusti","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.revmed.2005.03.002_bib3","first-page":"780","article-title":"Int\u00e9r\u00eat du dosage s\u00e9rique de la chromogranine A pour le d\u00e9pistage de ph\u00e9ochromocytome chez le patient hypertendus","volume":"96","author":"Biausque","year":"2003","journal-title":"Arch. Mal. Coeur Vaiss."},{"key":"10.1016\/j.revmed.2005.03.002_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/er.2002-0013","article-title":"Pheochromocytoma: State of the art and future prospects","volume":"24","author":"Bravo","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.revmed.2005.03.002_bib5","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/j.1572-0241.2001.03185.x","article-title":"Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies","volume":"96","author":"Bardhan","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.revmed.2005.03.002_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2036.1999.00466.x","article-title":"Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study","volume":"13","author":"Sanduleanu","year":"1999","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866305000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866305000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:14:16Z","timestamp":1759335256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866305000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0248866305000949"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2005.03.002","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Une cause \u00e0 conna\u00eetre d'\u00e9l\u00e9vation de chromogranine A\u00a0: les inhibiteurs de la pompe \u00e0 protons","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2005.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}